Articles On Genetic Technologies (ASX:GTG)

The ASX 200 falls flat  Small caps drop -0.1% Inflation inflates We’ll get to this in a moment. Via Google FinanceJosh, Reuben, Gregor and other bloodhounds have further details, as well.   In the meantime… Yikes. Annual inflation in the...

The ASX 200 trims gains to end circa 0.3% higher Small caps drop 0.2%, but C29 Metals booms China markets still choppy after political appointments   The big show, if balancing books and picking pre-chosen soundbytes is your thing, begins...

It’s quarterlies season again as the ASX market announcements page becomes increasingly flooded with earnings lodgements.  Several small caps from Tech and Healthcare released their reports today, showing that they’re still thriving despite...

Stockhead’s Top 10 at 10, published at 10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

ASX closes out the day lower by about 0.74% Online matchmakers Love Group goes on a bodice-busting 39% jag Woman tries to stop eviction with a swarm of bees. No, really…   Aussie markets are set to meander to a close around 0.74% down for...

Stockhead’s Top 10 at 10, published at 10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

ASX 200 ends 1.7% higher Small caps ahead 2.1% China’s odd. Hawson’s Iron down 75% this week. Toys R Us are killing it.   The ASX 200 and the Emerging Companies (XEC) index fell 1.7% and 2.1% respectively on Tuesday. Almost the full 11 se...

ASX 200 ends flat as Small caps s wee bit lower OLL investment sparks share price surge    We’re pretty flat on Wednesday. I am, the benchmark is and so is Australia as a nation and a continent. Luckily Gregor Stronach, my trusty fiend on...

Stockhead’s Top 10 at 10, published at 10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

ASX 200 abandoned play after decent start Small cap index gives back 1.3% Dundas shares jump on ultramafic magic   Local markets disappointed me today. So rather than start on an ill note, let’s take a quick spin around the Asia-Pacific...

ASX slides early and long on Monday Small cap index crashes -2.3% Besra Gold (ASX:BEZ) just tripled its own sense of self   We’re all in the same boat on Monday, floating aimlessly about the big blue of the Pacific amidst inflation and it...

Blood clot programs have taken the spotlight recently as new discoveries made Two ASX health stocks are in the blood clot space Top performing ASX healthcare stocks in the past month Blood clots were top of biotech news this week after re...

Stockhead’s Top 10 at 10, published at 10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

Small caps slip down 3.3%, and global markets look equally wobbly China’s manufacturing Purchasing Managers’ Index (PMI) actually grew in September  Alchemy Resources draws a ballot for some prospective lithium ground near big names in WA...

Benchmark set to end the day up 1.5% Small caps gain 2.2% Raiden Resources uses word visible,  Regional markets – pretty much led by ours – have risen in rare unison on Thursday thanks mainly to the wonderful stuff-up executed by UK Prime...

Nasdaq-listed Biogen says its experimental Alzheimer’s drug study was successful The news sends ASX-listed Cogstate to soar Orthocell could have the first FDA-approved injectable cell therapy in orthopaedics  Big news out of Nasdaq-listed...

ASX 200 down 0.5% Small caps  crash about 1.1% OXR up 50% on some quality HR     And that’s how you say Wednesday was merde in French. Let’s do some good news first. Aussie retail sales climbed for an eighth consecutive month in August,...

Benchmark rises early, wobbles late, gains 0.4% Small caps all over the shop today, up 0.9% Metals Grove jumps over 50%    Local markets have climbed the mountain of conflict today: (NB: explicit language).   The ASX 200 index was initia...

Stockhead’s Top 10 at 10, published at 10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

ASX 200 down 1.6% Small caps short 1.3% Real Estate stocks hit ahead of FOMC meet   The benchmark killed Tuesday only to find its very own number was up today. The ASX 200 has spent the session retracing yesterday’s 1.3% gains – driven b...

ASX 200 jumps on blue cap strength Small caps skulk around parity New Hope Coal: So. Much. New. Hope.   The benchmark is killing Tuesday, it’s up about 1.3% on big performances from the banks and the miners. The small cap XEC index is fla...

The ASX 200 is vacillating Small caps are down over 1.3% Demetallica is a great name and it’s up 40% on takeover talk   The benchmark ASX 200 is flat as on Monday. The ASX Emerging Companies (XEC) index has lost 1.3%. REITs and Gold are h...

The ASX200 is riding Wall Street’s coattails today up 044% Nine out of eleven sectors were higher, with real estate leading the charge Technology was a close second with the help of a unicorn takeover bid   Wall Street rallied on Friday a...

Stockhead’s Top 10 at 10, published at 10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

ASX 200 and small caps rise circa 1% Regional markets jump on strong leads, US inflation data Ragusa Metals: up 60% Local markets took off at the open, feeling a little of the excitement which took hold of Wall Street overnight. The bench...

ASX benchmark ends 0.6% ahead Peregrine’s gold rush slows, but still up more than 85% for the day The UK is looking awesome, if you’re a fan of recessions The ASX has had a pretty stable afternoon today, after the ASX 200 rose to a 0.5% g...

Small cap index up 3% ASX 200 is up 1% Wall Street jumps as The Fed asks how high The ASX 200 is up 1% and the Emerging Companies (XEC) index is about 3% higher and the wee buy now pay later’s are the heroes of the dish. But first…   Over...

  Stockhead’s Top 10 at 10, published at 10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest mover...

US FDA approves the first clinical trial using naturally derived psychedelic drugs It could open possibilities for other clinical trials to follow suit Best and worst biotechs over the past month In a ground-breaking development, the US F...

Benchmark up circa 1%, small caps surge 1.5% Coal miners eclipsed by Whitehaven record profits Kincora Copper finds so much more copper The small cap S&P/ASX Emerging Companies (XEC) index and the benchmark S&P/ASX 200 (XJO) index...

Ansell announces net zero commitment by 2040 Emyria extends its library of novel MDMA-like compounds  to >125 Genetic Technologies partners with Melbourne based Siles Health Protective personal equipment Ansell (ASX:ANN) has just annou...

Stockhead’s Top 10 at 10, published at 10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

Benchmark sags as Materials sector delivers even more tedious disappointment Coal miners hand back yesterday’s gains as investors tire of Chinese whispers Cannabis offers relief for investors and health stocks climb as well. The ASX has e...

Cynata receives notice from the US Patent Office GTG completes acquisition of AffinityDNA Dental clinic network Pacific Smiles announces earnings guidance Cell therapeutics specialist, Cynata Therapeutics (ASX:CYP), has just received a No...

Stockhead’s Top 10 at 10, published at 10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

Genetic Technologies (ASX:GTG) has completed the acquisition of the direct-to-consumer eCommerce business and distribution rights associated with AffinityDNA.

The ASX 200 ends ever so slightly up, XEC finds 0.4% Gains in consumer discretionary, tech offset big losses for energy, resources, materials. South Korea, Kiwi’s lift rates ahead of tonight’s US CPI read Investors are facing crunch time...

Stockhead’s Top 10 at 10, published at 10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

A recent research reveals which biotech segments VCs are ploughing billions of dollars into We list the ASX companies that are operating within those thematics We also list the best and worst ASX biotech performers over the past week and m...

Genetic Technologies (GTG) embarks on a significant expansion of its recent acquisition of EasyDNA in both its test portfolio and geographical reach EasyDNA had expanded the availability of its carrier testing and non-invasive prenatal tes...

Small Caps, ASX 200 accelerate after RBA rate call Cash rate to 1.35%, Capital Economics says 3.5% the target EasyDNA rocks GTG world   Forget the RBA, it’s small cap day at Stockhead  as the Little Legends index ignores war, floods, flu,...

Prescient gets US patent approval Genetic Technologies expands EasyDNA into India and Europe Imricor submits cardiac ablation catheter for EU market Clinical stage oncology company Prescient Therapeutics (ASX: PTX) has been granted a US p...

Stockhead’s Top 10 at 10, published at 10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

The ASX 200 and XEC small cap indices rise Attention turns to Tuesday’s date with RBA destiny Celsius Resources is hot   The ASX 200 and the Emerging Markets (XEC) indices are both trading higher on Monday up about 1.2%, ahead of tomorrow...

Literally every sector had a red month, but mining was the worst PayGroup gets surprise $120m takeover offer from US unicorn Deel Tempest Minerals signed JV to explore near the Karara Magnetite Iron mine June was a month of global econom...

Stockhead’s Top 10 at 10, published at 10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

Stockhead’s Top 10 at 10, published at 10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

Emerging Companies (XEC) index dives 2.6% Benchmark ASX200 down 0.6% Culpeo Minerals meets copper, shares up 70%   Aussie small caps have copped a commodities shellacking to start the week as materials, metals and energy stocks bear the...

Proteomics has completed a manufacturing technology transfer of its PromarkerD test Genetic Technologies build model that could create pathway in the US Proteomics proves it can produce the PromarkerD tests at scale Proteomics Internation...

Genetic Technologies (ASX:GTG) has completed an independently developed and validated customisable Budget Impact Model that it says demonstrates significant health and economic benefits directly attributed to the implementation of g...